Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stanley Aip Gp Lp Morgan currently holds 3,225,093 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley Aip Gp Lp Morgan has been a net seller of SGNT stock. They have purchased $0 and sold $17.8M worth of shares.
Stanley Aip Gp Lp Morgan's most recent insider trade was on Jan 23, 2015, when they sold 61,883 shares at $25.90 per share.
Stanley Aip Gp Lp Morgan serves as Executive at Sagent Pharmaceuticals, Inc. (SGNT). They have executed 12 insider transactions totaling $17.8M over their tenure at the company.
Stanley Aip Gp Lp Morgan holds the position of Executive at Sagent Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Stanley Aip Gp Lp Morgan has shown a selling trading pattern, with $0 in total purchases and $17.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stanley Aip Gp Lp Morgan was on Jan 22, 2015, when they sold $3.8M worth of SGNT shares. This transaction involved 150,000 shares at $25.49 per share.
Stanley Aip Gp Lp Morgan currently owns 3,225,093 shares of Sagent Pharmaceuticals, Inc. (SGNT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stanley Aip Gp Lp Morgan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stanley Aip Gp Lp Morgan has 12 Form 4 filings on record as an insider at Sagent Pharmaceuticals, Inc..
Set alerts for Stanley Aip Gp Lp Morgan and 40,000+ other insiders.